Buybacks in Progress at KOSPI/KOSDAQ: Stocks to Watch From a Trading Perspective
This post screens those buybacks in progress at KOSPI/KOSDAQ, which are worth noting from a short-term trading perspective.
Samsung C&T-Cheil Merger Trial Outcomes - Ramifications
We now have the outcome of the first trial on the Samsung C&T-Cheil merger, which began early last year. The Korean court said that the merger...
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
No more insights